|Articles|October 12, 2021

Veeva Announces Digital Trials Platform

Veeva Systems has announced the Veeva Digital Trials Platform, a solution aiming to advance clinical trial execution by providing a complete and connected technology ecosystem that spans patients, research sites, and trial sponsors. The Veeva Digital Trials Platform is available now for early adopters.

The product offering includes the following core solutions: Veeva Vault Clinical Suite, Veeva SiteVault Free, and MyVeeva for Patients.

More on Veeva’s Digital Trials Platform

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

ByAndy Studna, Senior Editor

September 4th 2026

Veeva Announces Digital Trials Platform

Related Content

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD

Beyond Patient Centricity: What Rare Disease Research Gets Right

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

Trending on Applied Clinical Trials Online

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

Beyond Patient Centricity: What Rare Disease Research Gets Right

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files